(from website) Avita Medical Limited is a publicly listed, global medical technology company trading on the Australian Stock Exchange (ASX:AVH). The company develops and distributes highly innovative products in Regenerative and Respiratory Medicine. The company's regenerative and tissue-engineered products provide revolutionary solutions utilising the patient's own skin and the regenerative capability of the human body to treat a wide range of wounds, scars and skin defects. ReCell® is a stand-alone, rapid cell harvesting device that enables surgeons to treat skin defects using the patient's own cells. The surgeon can prepare a small quantity of cells within 30 minutes on site replacing the current technique of skin grafting or the requirement to send a biopsy to the laboratory for culture. ReCell® has been designed for use in a wide variety of burns, plastic, reconstructive and cosmetic procedures.ReCell® is gaining acceptance in a number of indications including Vitiligo, a common skin pigmentation disease. ReCell® is patented, CE marked for the EU and TGA registered in Australia